Skip to main content

Dr. Thomas P. Harder, M.D.

Rheumatology (Rheumatology Physician)

  • Medicare participating

At a glance

Years since graduation
37
In the NPI registry since
2006
Medicare patients seen, 2024
662

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1989Medical school: Ohio State University College of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Rheumatology Physician primary
    PA license MD072001L

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Rheumatology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
662
Services billed
100,382
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)31,20012
Injection, denosumab, 1 mg16,680174
Established patient office or other outpatient visit, 30-39 minutes974512
Injection, methylprednisolone acetate, 40 mg409142
Aspiration and/or injection of fluid from large joint358128
Injection of drug or substance under skin or into muscle291176
Injection, triamcinolone acetonide, not otherwise specified, 10 mg25041
Established patient office or other outpatient visit, 20-29 minutes198148
Administration of chemotherapy into vein, 1 hour or less15426
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle15312

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 22 companies reported 205 payments worth $4,856 in total to this clinician.

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
May 6, 2025Janssen Biotech, Inc.
May 6, 2025
Education
TREMFYA · Immunology · in-kind
$77.99

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Pennsylvania →

Other Rheumatology clinicians in Wynnewood

Sources

NPI registry (CMS NPPES, November 2026; record last updated November 2, 2012), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1174568612. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.